ERK activation of p21 activated kinase-1 (Pak1) is critical for medulloblastoma cell migration

Por Yuan, Liangping, Santi, Mariarita, Rushing, Elisabeth J., Cornelison, Robert, MacDonald, Tobey J.
Publicado em 2010

Dasatinib suppression of medulloblastoma survival and migration is markedly enhanced by combining treatment with the aurora kinase inhibitor AT9283

Por Petersen, William, Liu, Jingbo, Yuan, Liangping, Zhang, Hongying, Schneiderjan, Matthew, Cho, Yoon-Jae, MacDonald, Tobey J.
Publicado em 2014

EphrinB1 expression is dysregulated and promotes oncogenic signaling in medulloblastoma

Por McKinney, Nicole, Yuan, Liangping, Zhang, Hongying, Liu, Jingbo, Cho, Yoon-Jae, Rushing, Elisabeth, Schniederjan, Matthew, MacDonald, Tobey J.
Publicado no J Neurooncol (2014)

Growth factor receptor-Src-mediated suppression of GRK6 dysregulates CXCR4 signaling and promotes medulloblastoma migration

Por Yuan, Liangping, Zhang, Hongying, Liu, Jingbo, Rubin, Joshua B, Cho, Yoon-Jae, Shu, Hui Kuo, Schniederjan, Matthew, MacDonald, Tobey J
Publicado em 2013

A MCP1 fusokine with CCR2-specific tumoricidal activity

Por Rafei, Moutih, Deng, Jiusheng, Boivin, Marie-Noëlle, Williams, Patrick, Matulis, Shannon M, Yuan, Shala, Birman, Elena, Forner, Kathy, Yuan, Liangping, Castellino, Craig, Boise, Lawrence H, MacDonald, Tobey J, Galipeau, Jacques
Publicado em 2011